{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:31:35Z","timestamp":1759969895720,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":599,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.maturitas.2011.09.005","type":"journal-article","created":{"date-parts":[[2011,10,10]],"date-time":"2011-10-10T17:01:35Z","timestamp":1318266095000},"page":"373-378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hormone therapy and coronary heart disease risk by vasomotor menopausal symptoms"],"prefix":"10.1016","volume":"70","author":[{"given":"Gerrie-Cor M.","family":"Gast","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor J.M.","family":"Pop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6ran N.","family":"Samsioe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diederick E.","family":"Grobbee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter M.","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jules J.","family":"Keyzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colette J.M.","family":"Wijnands-van Gent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne T.","family":"van der Schouw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2011.09.005_bib0005","doi-asserted-by":"crossref","first-page":"933","DOI":"10.7326\/0003-4819-133-12-200012190-00008","article-title":"A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease","volume":"133","author":"Grodstein","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0010","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0033-0620(95)80012-3","article-title":"The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women","volume":"38","author":"Grodstein","year":"1995","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0091-7435(91)90006-P","article-title":"Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence","volume":"20","author":"Stampfer","year":"1991","journal-title":"Prev Med"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0020","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/progestin Replacement Study (HERS) Research Group","volume":"280","author":"Hulley","year":"1998","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0030","first-page":"351","article-title":"A prospective population-based study of menopausal symptoms","volume":"96","author":"Dennerstein","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0035","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0140-6736(02)11774-0","article-title":"Hot flushes","volume":"360","author":"Stearns","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0040","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/cmt.6.2.112.117","article-title":"Health care-seeking for menopausal problems","volume":"6","author":"Guthrie","year":"2003","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0045","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0050","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1001\/jama.292.16.1983","article-title":"Promotion and prescribing of hormone therapy after report of harm by the women's health initiative","volume":"292","author":"Majumdar","year":"2004","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/01.GME.0000108177.85442.71","article-title":"Treatment of menopause-associated vasomotor symptoms: position statement of the North American Menopause Society","volume":"11","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0060","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/gme.0b013e31803167ab","article-title":"Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of the North American Menopause Society","volume":"14","year":"2007","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0065","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/eurheartj\/ehi297","article-title":"Menopausal complaints, oestrogens, and heart disease risk: an explanation for discrepant findings on the benefits of post-menopausal hormone therapy","volume":"26","author":"van der Schouw","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0070","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/gme.0b013e3181a4866b","article-title":"Vasomotor symptoms and mortality: the Rancho Bernardo Study","volume":"16","author":"Svartberg","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0075","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1161\/HYPERTENSIONAHA.107.106526","article-title":"Menopausal complaints are associated with cardiovascular risk factors","volume":"51","author":"Gast","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0080","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.maturitas.2010.03.015","article-title":"Vasomotor symptoms, estradiol levels and cardiovascular risk profile in women","volume":"66","author":"Gast","year":"2010","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0085","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/gme.0b013e3181f464fb","article-title":"Vasomotor menopausal symptoms are associated with increased risk of coronary heart disease","volume":"18","author":"Gast","year":"2011","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0090","article-title":"Vasomotor symptoms and cardiovascular events in postmenopausal women","author":"Szmuilowicz","year":"2011","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0095","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/gme.0b013e31819c11e4","article-title":"Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women","volume":"16","author":"Huang","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0100","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","article-title":"Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause","volume":"297","author":"Rossouw","year":"2007","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0197-2456(97)00078-0","article-title":"Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group","volume":"19","year":"1998","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0110","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0197-2456(98)00010-5","article-title":"Heart and Estrogen\/progestin Replacement Study (HERS): design, methods, and baseline characteristics","volume":"19","author":"Grady","year":"1998","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0115","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s001980050083","article-title":"The prevalence of low bone mineral density in Dutch perimenopausal women: the Eindhoven perimenopausal osteoporosis study","volume":"8","author":"Smeets-Goevaers","year":"1998","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.maturitas.2009.11.009","article-title":"The women's health in the Lund area (WHILA) study \u2013 an overview","volume":"65","author":"Samsioe","year":"2010","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0125","first-page":"399","article-title":"Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition","volume":"18","author":"Friedenreich","year":"2007","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0130","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.atherosclerosis.2004.04.001","article-title":"The increase in cholesterol with menopause is associated with the apolipoprotein E genotype. A population-based longitudinal study","volume":"175","author":"Hak","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0135","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jclinepi.2006.01.014","article-title":"Review: a gentle introduction to imputation of missing values","volume":"59","author":"Donders","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0140","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/gme.0b013e318185e25b","article-title":"Vasomotor symptoms are associated with a lower bone mineral density","volume":"16","author":"Gast","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0145","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/jech.46.2.136","article-title":"Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts","volume":"46","author":"Herings","year":"1992","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0150","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1023\/A:1007634722658","article-title":"Comparison of different procedures to identify probable cases of myocardial infarction and stroke in two Swedish prospective cohort studies using local and national routine registers","volume":"16","author":"Merlo","year":"2000","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0155","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/01.CIR.90.1.583","article-title":"Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents","volume":"90","author":"Tunstall-Pedoe","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0160","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(96)91278-7","article-title":"Country profile: Sweden","volume":"347","author":"Calltorp","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0165","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/152460901750067133","article-title":"Hot flashes in the late reproductive years: risk factors for Africa American and Caucasian women","volume":"10","author":"Freeman","year":"2001","journal-title":"J Womens Health Gend Based Med"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-5273(02)00307-8","article-title":"Can a healthy endothelium influence the cardiovascular effects of hormone replacement therapy?","volume":"87","author":"Koh","year":"2003","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0175","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.fertnstert.2004.11.012","article-title":"Postmenopausal hormone therapy: critical reappraisal and a unified hypothesis","volume":"83","author":"Phillips","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0180","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/gme.0b013e3181aa30ff","article-title":"The complex interplay of vasomotor symptoms, hormone therapy, and cardiovascular risk","volume":"16","author":"Allison","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0185","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/13697131003624656","article-title":"Hot flushes and biochemical markers for cardiovascular disease: a randomized trial on hormone therapy","volume":"13","author":"Tuomikoski","year":"2010","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0190","series-title":"Treatment of the Postmenopausal Woman","first-page":"529","article-title":"Randomized controlled trials and the effects of postmenopausal hormone therapy on cardiovascular disease: facts, hypotheses and clinical perspective","author":"Hodis","year":"2007"},{"key":"10.1016\/j.maturitas.2011.09.005_bib0195","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.brainres.2010.10.076","article-title":"A \u201cwindow of opportunity\u201d: the reduction of coronary heart disease and total mortality with menopausal therapies is age- and time-dependent","volume":"1379","author":"Hodis","year":"2011","journal-title":"Brain Res"},{"issue":"Suppl. 1","key":"10.1016\/j.maturitas.2011.09.005_bib0200","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/13697130903007389","article-title":"Type and route of estrogen administration","volume":"12","author":"Stevenson","year":"2009","journal-title":"Climacteric"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512211003240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512211003240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:53:07Z","timestamp":1759913587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512211003240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0378512211003240"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2011.09.005","relation":{},"ISSN":["0378-5122"],"issn-type":[{"type":"print","value":"0378-5122"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hormone therapy and coronary heart disease risk by vasomotor menopausal symptoms","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2011.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}